The role of immune checkpoint inhibitor therapy in advanced adrenocortical carcinoma revisited: review of literature.

Eloá Pereira Brabo Aline Barbosa Moraes Leonardo V Neto

Published in: Journal of endocrinological investigation (2020)

ICI, mainly pembrolizumab, is a potential therapeutic option, which is safe and associated with prolonged OS benefit, in selected patients with advanced ACC.

Keyphrases

advanced non small cell lung cancer
stem cells
mesenchymal stem cells
bone marrow
smoking cessation
tyrosine kinase